Increasing miR142-3p activity did not further reduce Treg induction efficacy in naive CD4+ T cells from children with recent onset of T1D (Fig. 3d) or individuals with established T1D (Fig. 3e), presumably because miR142-3p levels were already saturated in these cells. This evidence concerns the gene CD4 and type 1 diabetes mellitus.